# Mazdutide vs dulaglutide in type 2 diabetes: HbA1c, weight

Source: https://pepvault.app/research/mazdutide-guo-2026

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Mazdutide](https://pepvault.app/research#mazdutide)

Randomized trial · people

# Mazdutide beat dulaglutide on HbA1c and weight at 28 weeks

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In this head-to-head trial, mazdutide lowered blood sugar and weight more than dulaglutide 1.5 mg over 28 weeks, with more stomach and gut side effects.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 731
- **Published:** 2026
- **Journal:** Nature

## What they tested

The team tested whether weekly mazdutide controls blood sugar and body weight better than dulaglutide in adults with type 2 diabetes already on diabetes pills.

## How the study was done

A randomized phase III trial in 731 Chinese adults with type 2 diabetes who stayed on their usual oral diabetes drugs. Participants were split evenly among the 4 mg mazdutide arm, the 6 mg mazdutide arm and the 1.5 mg dulaglutide arm for 28 weeks.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking mazdutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Both mazdutide arms lowered HbA1c (a long-term average of blood sugar) more than dulaglutide, with a treatment difference of -0.24% in the 4 mg arm (P = 0.0032) and -0.30% in the 6 mg arm (P = 0.0003). Weight dropped more too, with a treatment difference of -3.78% for the 4 mg arm and -5.76% for the 6 mg arm versus dulaglutide (both P < 0.0001). More people on either mazdutide dose reached both an HbA1c under 7.0% and at least 5% weight loss by week 28 (both P < 0.0001). Diarrhea, nausea and vomiting were the most common side effects, and stomach and gut side effects were more frequent with mazdutide than with dulaglutide.

## What it doesn’t show

The trial ran for 28 weeks and included only Chinese adults with type 2 diabetes, so it does not show longer-term results or how other groups respond. It compared mazdutide with one dulaglutide dose, not with other diabetes or weight medicines.

## The paper

Guo et al. Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes. Nature. 2026.

- [PubMed (PMID 41407860)](https://pubmed.ncbi.nlm.nih.gov/41407860/)
- [The paper (DOI 10.1038/s41586-025-10031-z)](https://doi.org/10.1038/s41586-025-10031-z)
- [ClinicalTrials.gov (NCT05606913)](https://clinicaltrials.gov/study/NCT05606913)

## The compounds

- [Mazdutide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/mazdutide)
- [Dulaglutide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/dulaglutide)
- [Mazdutide dose guide](https://pepvault.app/lab/dosage/mazdutide)
- [Dulaglutide dose guide](https://pepvault.app/lab/dosage/dulaglutide)

## With this study

### Mazdutide

- [Mazdutide: the full reference](https://pepvault.app/peptides/mazdutide)
- [Mazdutide dose guide](https://pepvault.app/lab/dosage/mazdutide)

### Dulaglutide

- [Dulaglutide: the full reference](https://pepvault.app/peptides/dulaglutide)
- [Dulaglutide dose guide](https://pepvault.app/lab/dosage/dulaglutide)

### Mixing charts

- [Mazdutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/mazdutide-10mg)

### Studies

- [Mazdutide: 16.65% average weight loss at 60 weeks in GLORY-2](https://pepvault.app/research/mazdutide-glory-2-2026)
- [Mazdutide: HbA1c fell 2.15% at 24 weeks in type 2 diabetes](https://pepvault.app/research/mazdutide-zhu-2026)
- [All 4 studies](https://pepvault.app/research#mazdutide)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [Dulaglutide cut HbA1c 1.3 vs 2.4 to 2.8 with tirzepatide at 52 weeks](https://pepvault.app/research/dulaglutide-surpass-j-mono-2022)
- [All 7 studies](https://pepvault.app/research#dulaglutide)

### Compared with

- [Mazdutide vs Tirzepatide](https://pepvault.app/peptides/compare/mazdutide-vs-tirzepatide)
- [Retatrutide vs Mazdutide](https://pepvault.app/peptides/compare/retatrutide-vs-mazdutide)
- [Mazdutide vs Survodutide](https://pepvault.app/peptides/compare/mazdutide-vs-survodutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

## More studies on Mazdutide

- [Mazdutide: 16.65% average weight loss at 60 weeks in GLORY-2](https://pepvault.app/research/mazdutide-glory-2-2026) Randomized trial · people · 2026
- [Mazdutide: HbA1c fell 2.15% at 24 weeks in type 2 diabetes](https://pepvault.app/research/mazdutide-zhu-2026) Randomized trial · people · 2026
- [Mazdutide: 14.01% weight loss at 48 weeks in GLORY-1 (6 mg arm)](https://pepvault.app/research/mazdutide-glory-1-2025) Randomized trial · people · 2025
- [Every study on Mazdutide](https://pepvault.app/research#mazdutide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking mazdutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking mazdutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Mazdutide

- [Mazdutide: the full reference](https://pepvault.app/peptides/mazdutide)
- [Mazdutide dose guide](https://pepvault.app/lab/dosage/mazdutide)

### Dulaglutide

- [Dulaglutide: the full reference](https://pepvault.app/peptides/dulaglutide)
- [Dulaglutide dose guide](https://pepvault.app/lab/dosage/dulaglutide)

### Mixing charts

- [Mazdutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/mazdutide-10mg)

### Studies

- [Mazdutide: 16.65% average weight loss at 60 weeks in GLORY-2](https://pepvault.app/research/mazdutide-glory-2-2026)
- [Mazdutide: HbA1c fell 2.15% at 24 weeks in type 2 diabetes](https://pepvault.app/research/mazdutide-zhu-2026)
- [All 4 studies](https://pepvault.app/research#mazdutide)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [Dulaglutide cut HbA1c 1.3 vs 2.4 to 2.8 with tirzepatide at 52 weeks](https://pepvault.app/research/dulaglutide-surpass-j-mono-2022)
- [All 7 studies](https://pepvault.app/research#dulaglutide)

### Compared with

- [Mazdutide vs Tirzepatide](https://pepvault.app/peptides/compare/mazdutide-vs-tirzepatide)
- [Retatrutide vs Mazdutide](https://pepvault.app/peptides/compare/retatrutide-vs-mazdutide)
- [Mazdutide vs Survodutide](https://pepvault.app/peptides/compare/mazdutide-vs-survodutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

<!--promo-->

PepVault for iPhone

## Taking mazdutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Mazdutide](https://pepvault.app/research#mazdutide)

## The library

- [Mazdutide](https://pepvault.app/peptides/mazdutide)
- [Mazdutide dose guide](https://pepvault.app/lab/dosage/mazdutide)
- [Dulaglutide](https://pepvault.app/peptides/dulaglutide)
- [Dulaglutide dose guide](https://pepvault.app/lab/dosage/dulaglutide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, Victoza and Trulicity are trademarks of their respective owners; PepVault is independent and not affiliated with or endorsed by any manufacturer.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
